STOCK TITAN

Cassava Sciences Invited by the NIH to Participate in Sachs 4th Annual Neuroscience Innovation Forum

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary

AUSTIN, Texas, April 26, 2021 (GLOBE NEWSWIRE) -- Cassava Sciences, a clinical-stage biotechnology company focused on Alzheimer’s disease, has been invited to the Sachs 4th Annual Neuroscience Innovation Forum, taking place virtually from April 28-30, 2021. The National Institute on Aging of the NIH will feature Cassava's scientific program during this event. Dr. Lindsay Burns, Senior VP of Neuroscience, will present a 10-minute overview of their Alzheimer’s program. The webcast will be available on Cassava’s website starting April 28 at 8:30 AM ET.

Positive
  • None.
Negative
  • None.

AUSTIN, Texas, April 26, 2021 (GLOBE NEWSWIRE) -- Cassava Sciences, Inc. (Nasdaq: SAVA), a clinical-stage biotechnology company focused on Alzheimer’s disease, today announced that it has been invited to participate in the Sachs 4th Annual Neuroscience Innovation Forum, a virtual event held on April 28-30, 2021. The National Institute on Aging of the National Institutes of Health (NIH) has invited Cassava Sciences to showcase its scientific program at this event.

Lindsay Burns, PhD, Senior VP Neuroscience, will provide a pre-recorded, 10-minute overview of Cassava Sciences’ program in Alzheimer’s disease during this event. A link for this webcast will be available on Cassava Sciences’ website on Wednesday, April 28th starting 8:30AM Eastern time and will remain there for approximately 90 days thereafter.

About Cassava Sciences, Inc.
Cassava Sciences’ mission is to discover and develop innovations for chronic, neurodegenerative conditions. Over the past 10 years, Cassava Sciences has combined state-of-the-art technology with new insights in neurobiology to develop novel solutions for Alzheimer’s disease. For more information, please visit: https://www.CassavaSciences.com.

For More Information Contact:
Eric Schoen, Chief Financial Officer
eschoen@CassavaSciences.com
(512) 501-2450


FAQ

What is Cassava Sciences participating in on April 28-30, 2021?

Cassava Sciences is participating in the Sachs 4th Annual Neuroscience Innovation Forum.

Who will present at the Neuroscience Innovation Forum for Cassava Sciences?

Dr. Lindsay Burns, Senior VP of Neuroscience, will present a pre-recorded overview.

When will the Cassava Sciences webcast be available?

The webcast will be available starting April 28, 2021, at 8:30 AM ET for approximately 90 days.

What is the focus of Cassava Sciences?

Cassava Sciences is focused on developing innovations for Alzheimer’s disease and other chronic neurodegenerative conditions.

Where can I find more information about Cassava Sciences?

More information can be found on Cassava Sciences' official website.

Cassava Sciences, Inc.

NASDAQ:SAVA

SAVA Rankings

SAVA Latest News

SAVA Stock Data

1.35B
41.69M
13.38%
29.95%
38.71%
Biotechnology
Pharmaceutical Preparations
Link
United States of America
AUSTIN